Robert J. Milligan
Firm: Milligan Lawless, P.C.
Address: 5050 North 40th Street, Suite 200
Phoenix, AZ 85018
Membership: Maricopa County and American (Member, Health Law Litigation Committee) Bar Associations; State Bar of Arizona; American Medical Association (Member, Doctors Advisory Network); American Health Lawyers Association; Arizona Association of Health C
University: Northern Illinois University, B.S., 1975, DePaul University, J.D., 1980; Arizona State University, LL.M., Biotechnology/Genomics, 2007
Admitted: 1980, Illinois, U.S. District Court, Northern District of Illinois and U.S. Court of Appeals, Seventh Circuit; 1986, Arizona
Biography: Robert J. Milligan is a Shareholder in the Phoenix, Arizona law firm of Milligan Lawless Taylor Murphy & Bailey, P.C. and specializes in health care law. Mr. Milligan limits his practice to the representation of individuals and companies in the health care and life sciences industry. Mr. Milligan's experience includes: Formation and operation of ASCs, imaging centers and other ventures; Mergers and acquisitions; Advice and representation relating to clinical research, clinical trial agreements, medical education, FDA compliance and related issues; Fraud and abuse advice, including internal investigations, self-reporting and compliance program development; Medical staff representation, including medical staff governance, peer review, medical staff-hospital relations and EMTALA compliance; Managed care contract negotiation and drafting, including capitation and other risk-based agreements; Advice regarding antitrust, licensing, medical research, Medicare and Medicaid reimbursement, corporate and partnership law, and general business issues. In addition to his law practice, Mr. Milligan has received an LL.M. degree in Biotechnology and Genomics. In that capacity, he completed coursework and independent study in: FDA regulation; pharmacogenomics; biotechnology science; law and policy; clinical research ethics; reimbursement; technology transfer; and technology licensing. He researches and writes on topics relating to biotechnology. Mr. Milligan's papers include: "FDA and the Role of Pharmacogenomics in Drug Development" (2005); "Pharmacogenomics in Clinical Practice: Opportunities and Challenges" (2005); "Coverage and Reimbursement for Pharmacogenomic Testing" (2006); and "Pharmacogenomics and the Early Termination of Clinical Trials; Selected Ethical Issues" (2006). Mr. Milligan focuses on solving problems and building relationships through mediation: The Firm's focus on creative problem-solving is reflected in the development of its health care mediation practice, headed by Mr. Milligan. "In health care, disputes often arise between parties that need each other. By and large, physicians need hospitals, hospitals need physicians, and they both need payors. While a physician group and a hospital may be engaged in a bitter dispute over one issue, the scorched earth approach to conflict resolution makes future cooperation difficult or impossible. Through mediation, parties can resolve disputes and build strong foundations for the types of collaboration that new payment programs, such as accountable healthcare organizations, will require." Mr. Milligan is also a Board Member for the Center for Law, Science and Innovation, Arizona State University Sandra Day O'Connor College of Law Advisory.Bar Fellowship: Ear Foundation of Arizona.